Revance Therapeutics (RVNC:NAS) Fundamental Valuation Report
Fundamental Valuation Report Revance Therapeutics(RVNC:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$27.93 (USD) 05/12/2021 Weighted Valuation$30.10 (USD) Overall RatingUndervalued by 7.8% Valuation Models Adjusted Book Value: $22.74 (USD) …
Revance Therapeutics (RVNC:NAS) Fundamental Valuation Report Read more »
Read More